We use cookies to provide essential features and services. By using our website you agree to our use of cookies .

×

COVID-19 Response at Fishpond

Read what we're doing...

Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries
By

Rating

Product Description
Product Details

Table of Contents

Contents: Foreword; Introduction; Part I The Challenge: Novel market challenges; What is intellectual property? Part II Models and Solutions: Market opportunities; Modeling and forecasting; Valuation; Development costs of intellectual property; Commercial strategy for intellectual property; Marketing intellectual property in healthcare; Licensing, selling and finance; Contract execution; Agreements; Summary; Index.

About the Author

Martin Austin is Managing Director of TransformRx GmbH, formed in 2005 to provide business advice to clients on investment and business development. He is also a Partner in MarraM Advisors, specialising in Industrial Biotechnology, a Board member of RSA AG and Chairman of Zestagen SA a biotech start-up in Lausanne. He was previously a Principal in the Paul Capital Partners Royalty Funds, a USA-based specialist in Secondary Private Equity and Alternative Asset Investments and previously Head of Business Development for the Pharmaceuticals Division at F. Hoffmann-La Roche. After a broad ranging career in the Pharmaceutical industry, progressing through Sales and Marketing roles with GD Searle in the early 1980's, he went on to become Business Development Manager with Lorex Pharmaceuticals before leaving to become a founding Director of Machine Intelligence Technologies. He was then appointed Managing Director of MHIG Ltd, an international joint venture in Market Research, prior to joining Roche.

Ask a Question About this Product More...
Write your question below:
Look for similar items by category
People also searched for
Item ships from and is sold by Fishpond World Ltd.
Back to top